RECIST vs. WHO: Prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma

European Journal of Cancer

Volumn 41, Issue 10, 2005, Pages 1426-1430

  Therasse, P ^a   Le Cesne, A ^b   Van Glabbeke, M ^a   Verweij, J ^c   Judson, I ^d  

^a EORTC DATA CENTER   (Belgium)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Clinical trials; Prospective validation; RECIST; WHO

Indexed keywords

ANTINEOPLASTIC AGENT; TRABECTEDIN;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EVALUATION; HUMAN; INTERMETHOD COMPARISON; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RESPONSE EVALUATION CRITERIA IN SOLID TUMOR; SOFT TISSUE SARCOMA; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

ANTINEOPLASTIC AGENTS, ALKYLATING; DIOXOLES; DISEASE PROGRESSION; HUMANS; ISOQUINOLINES; PROSPECTIVE STUDIES; SARCOMA; TETRAHYDROISOQUINOLINES; TREATMENT OUTCOME;

EID: 20444502848     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.04.005     Document Type: Article

References (15)

1. P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 2000 205 216
2. A.B. Miller, B. Hogestraeten, and M. Staquet Reporting results of cancer treatment Cancer 47 1981 207 214
3. S. Green, and G.R. Weiss Southwest oncology group standard response criteria, endpoint definitions and toxicity criteria Invest New Drugs 10 1992 239 253
4. Tumor eligibility and response criteria for phase II and III studies. EORTC Data Center Manuel. Brussels, 1992, monograph
5. M. Van Glabbeke, A.T. van Oosterom, and W. Steward Selection of large and objectively measurable target lesions in EORTC phase II trials: impact on recruitment and response rate. EORTC soft tissue and bone sarcoma group (STBSG) Eur J Cancer 29 1993 1943 1947
6. M. Van Glabbeke, A.T. van Oosterom, and J.W. Oosterhuis Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2185 patients treated with anthracycline-containing first-line regimens - a European organization for research and treatment of cancer soft tissue and bone sarcoma group study J Clin Oncol 17 1999 150 157
7. A. Le Cesne, J.Y. Blay, and I. Judson Phase II study of ET-743 in advanced soft tissue sarcomas: a European organisation for the research and treatment of cancer (EORTC) soft tissue and bone sarcoma group trial J Clin Oncol 23 2005 576 584
8. M. Werner-Wasik, Y. Xiao, and E. Pequignot Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study Int J Radiat Oncol Biol Phys 51 2001 56 61
9. V. Trillet-Lenoir, G. Freyer, and P. Kaemmerlen Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria Br J Radiol 75 2002 903 908
10. S.R. Prasad, S. Saini, and J.E. Sumner Radiological measurement of breast cancer metastases to lung and liver: comparison between WHO (bidimensional) and RECIST (unidimensional) guidelines J Comput Assist Tomogr 27 2003 380 384
11. J.J. Erasmus, G.W. Gladish, and L. Broemeling Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment to tumor response J Clin Oncol 21 2003 2574 2582
12. M.J. Byrne, and A.K. Nowak Modified RECIST criteria for assessment of response in malignant pleural mesothelioma Ann Oncol 15 2004 257 260
13. K. Konishi, K. Kuriyama, and S. Chino CT evaluation of response to chemotherapy and/or radiotherapy in primary lung cancer: comparison of response evaluation criteria in solid tumors (RECIST) and the WHO criteria, and comparison of both methods with the histological evaluation Nippon Igaku Hoshasen Gakkai Zasshi 64 1 2004 41 45
14. F. Grossi, O. Belvedere, and G. Fasola Tumor measurements on computed tomographic images of non-small cell lung cancer were similar among cancer professionals from different specialties J Clin Epidemiol 57 2004 804 808
15. R.J. van Klaveren, J.G. Aerts, and H. de Bruin Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma Lung Cancer 43 2004 63 69